Atlas Trials

Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03)

Clinical trial NCT03052062 · COMPLETED

Trial details

NCT number
NCT03052062
Sponsor
Valbiotis
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Obese
Start date
2017-03-02
Primary completion
2018-07-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.